At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
King Vision video Laryngoscopedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
King Vision Video Laryngoscope aBlade System for Use in Children
In Brief
A clinical study evaluating King Vision video Laryngoscope for Pediatric Anesthesia and King Vision Video Laryngoscope Intubation. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This is a single center trial to evaluate the performance of the King Vision video laryngoscope in pediatric patients between the ages of one month and 10 years of age. If the performance is satisfactory, this device may become a standard laryngoscope for tracheal intubation in elective and emergent tracheal intubations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsKing Systems Corporation
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedJul 2016
Primary CompletionNov 2017
TodayJul 2026
First PostedJul 22, 2016
Enrollment StartDec 1, 2014
Primary CompletionNov 7, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.9 years ago
Interventions
King Vision video Laryngoscopedevice
The King Vision video laryngoscope (Ambu) will be used for tracheal intubation.